Background Psoriasis is a common long-term, immune-mediated skin condition associated with behavioural factors (e.g. smoking, excess alcohol, obesity), which increase the risk of psoriasis onset, flares and comorbidities. Motivational interviewing (MI) is an evidence-based approach to health-related behaviour change that has been used successfully for patients with long-term conditions. This study assessed change in clinicians' MI skills and psoriasis knowledge following Psoriasis and Wellbeing (Pso Well â ) training.
Summary
Background Psoriasis is a common long-term, immune-mediated skin condition associated with behavioural factors (e.g. smoking, excess alcohol, obesity), which increase the risk of psoriasis onset, flares and comorbidities. Motivational interviewing (MI) is an evidence-based approach to health-related behaviour change that has been used successfully for patients with long-term conditions. This study assessed change in clinicians' MI skills and psoriasis knowledge following Psoriasis and Wellbeing (Pso Well â ) training.
Objectives To investigate whether the Pso Well training intervention improves clinicians' MI skills and knowledge about psoriasis-related comorbidities and risk factors; and to explore the acceptability and feasibility of the Pso Well training content, delivery and evaluation.
Methods Clinicians attended the 1-day training programme focused on MI skills development in the context of psoriasis. MI skills were assessed pre-and posttraining using the Behaviour Change Counselling Index. Knowledge about psoriasis-related comorbidity and risk factors was assessed with a novel 22-point measure developed for the study. Interviews with clinicians were analysed qualitatively to identify perceptions about the feasibility and acceptability of the training.
Results Sixty-one clinicians completed the training (35 dermatology nurses, 23 dermatologists and three primary-care clinicians). Clinicians' MI skills (P < 0Á001) and knowledge (P < 0Á001) increased significantly post-training. Clinicians found the training valuable and relevant to psoriasis management. Conclusions Attendance at the Pso Well training resulted in improvements in clinicians' knowledge and skills to manage psoriasis holistically. Clinicians deemed the training itself and the assessment procedures used both feasible and acceptable. Future research should investigate how this training may influence patient outcomes.
What's already known about this topic?
• Holistic care of people with psoriasis requires knowledge about and management of comorbidities and associated risk factors.
• Motivational interviewing can support people with long-term conditions to make necessary changes to health-related behaviours.
What does this study add?
• The first evaluation of motivational interviewing skills training for clinicians managing patients with psoriasis.
• Psoriasis-tailored motivational interviewing training assists clinicians to manage psoriasis holistically and support behaviour change.
What are the clinical implications of this work?
• The Pso Well â training is acceptable to clinicians and feasible to run within U.K.
healthcare settings.
Psoriasis is a complex immune-mediated skin condition affecting approximately 2% of the U.K. population. 1 Associations between psoriasis and other physical and psychological comorbidities are well established, including cardiovascular disease, metabolic disease and diabetes 2, 3 ; psoriatic arthritis 4 ;
Crohn disease 5 ; and anxiety, depression and suicidality. 6 Behavioural factors that increase individuals' risk of developing or exacerbating psoriasis and its comorbidities include smoking, 7-9 obesity, [8] [9] [10] [11] [12] physical inactivity, 13,14 excess alcohol consumption [15] [16] [17] [18] and poor medication adherence.
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Psychological distress related to living with psoriasis may also limit an individual's quality of life and capacity for effective self-management. 17, [21] [22] [23] [24] [25] Holistic psoriasis management therefore requires understanding of the relationships between psoriasis, distress and behavioural factors, 26 as well as the skills to help patients achieve behavioural changes. Behavioural change is notoriously difficult, 27 and our earlier studies demonstrated that clinicians working with people with psoriasis miss opportunities to address behaviour change topics within clinical consultations. 28, 29 Clinicians also report lacking the confidence and skills to address lifestyle behaviour change in psoriasis consultations, [28] [29] [30] and view psoriasis as a simple skin condition rather than a complex long-term condition requiring integrated management of behavioural factors. 26, 30, 31 We therefore developed a 1-day training programme for clinicians to manage psoriasis and support patient behaviour change within standard dermatology consultations. The U.K.'s Medical Research Council guidelines advocate an iterative approach to the development of complex interventions, in which design and evaluation inform one another, moving from exploratory studies to more definitive evaluation phases. 32 The resulting interventions are more likely to be effective and implementable within a target care setting due to the process of evidence-based evaluation/revision. Trials of such interventions are also less likely to fail due to problems of acceptability, intervention delivery or insensitivity to local context. 32 As an initial step in this process, we assessed whether clinicians acquire new psoriasis management skills following attendance at this training programme.
Motivational interviewing (MI) is an evidence-based approach that strengthens motivation to change health behaviours by eliciting people's beliefs about change, collaboratively developing goals, and increasing confidence to achieve change. 33 
Patients and methods

Design
This before-and-after, exploratory investigation of a 1-day training programme was conducted in small groups of clinicians from a range of practice settings. An embedded qualitative study was used to explore clinicians' experiences and perceptions of the training. Institutional research ethics approval was obtained (reference 14223). 
Participant recruitment
Measures
Clinicians' motivational interviewing skills
The Behaviour Change Counselling Index (BECCI) is a valid and reliable 11-item skills checklist that assesses core MI competencies. 40 Clinicians participated in two, 10-min audio-taped consultations with trained and experienced patient actors, immediately before and immediately after the Pso Well â training. Four patient actors (two male, two female) were used to standardize the assessment delivery. The scripts provided to the patient actors were developed by members of the research team to form anonymous, composite patient cases, with content based on both clinical experience and patient research. The scripts were standardized for length and depth of content, as well as the number and type of cues about behavioural risk factors (e.g. obesity, alcohol, low mood) that patients would provide during assessments. Completed audio recordings were reviewed by an independent panel of seven trained BECCI raters from psychology, health economics, health care and health services research. Raters were trained by A.C. or C.B. (experienced MI trainers) during three standardization meetings to calibrate approaches to scoring, and then blinded to pre-and post-training audio tapes. The team was assessed for inter-rater reliability by comparing two audio recordings each against a 'gold standard' scorer (MI trainer). Intraclass correlation coefficients (ICCs) indicated 'almost perfect' agreement 41 on the mean BECCI score [ICC 0Á93, 95% confidence interval (CI) 0Á75-0Á98; P < 0Á001] and total BECCI score (ICC 0Á93, 95% CI 0Á77-0Á98; P < 0Á001). The primary outcome was change in clinicians' BECCI score. A change of 0Á8 between the before and after scores was considered adequate to measure responsiveness on this measure, 40 although the study was initially powered to detect a change of 0Á4. To have 80% power to detect this change as statistically significant at the 5% level required a minimum sample size of 41 clinicians. Clinicians working with an MI approach are expected to talk less than patients (i.e. < 50% of total consultations time), therefore, BECCI raters also estimated the percentage of time that clinicians talked during consultations compared with patients. Coders' estimates of 'talk time' were compared with objectively calculated talk time throughout training to optimize consistency with actual clinician talk time. This measure is recommended as a supplementary indicator of an MI-consistent consultation approach. 40 Patient actors participating in consultations with clinicians provided written feedback on their evaluation of clinicians' skills pre-and post-training using a five-point Likert scale (with five items) plus open-text responses, which were categorized with content analysis. Likert scale items addressed the degree to which patient actors felt (i) they were listened to in the consultation; (ii) the clinician understood how they were feeling; (iii) they were confident to make behavioural changes following the consultation; (iv) that the clinician provided constructive information; and (v) they talked more than the clinician about ways to improve their health.
Knowledge of psoriasis-related comorbidities and risk factors
A 22-item survey assessing current knowledge about psoriasisrelated comorbidities and risk factors was devised for this study by experts in psoriasis and its comorbidities, and checked for accuracy and ease or difficulty of comprehension with the wider research team. The survey assessed knowledge about (i) psoriasis-related comorbidities; (ii) prevalence of behavioural (smoking, alcohol, obesity, physical inactivity) and mood (anxiety, depression, stress) factors in psoriasis; and (iii) associations between psoriasis and behavioural and mood factors. The maximum scores were nine points, 19 points and seven points, respectively; the total maximum score was 35.
To assess the degree to which clinicians applied their knowledge of psoriasis-related risk factors in consultations with patient actors in a simulated practice setting, the audiorecorded consultations were coded for two additional items. Firstly, researchers scored the clinicians from 0 (not at all) to 4 (a great extent) on the question, 'Did the clinician make links between psoriasis and behaviour change topics?' Secondly, raters were asked to note the 'behaviour change topics' arising during 10-min consultations to capture the range and type of topics clinicians chose to discuss with patients before and after training.
Analysis
Descriptive analyses were conducted on participant demographics and the frequency and range of topics discussed during audio-recorded consultations. The primary outcome measures (BECCI skills and knowledge survey) were analysed using within-group comparisons (paired-samples t-tests and Wilcoxon signed-rank tests) in order to assess change over time. Small amounts of missing data (fewer than three items on any measure) were managed using imputation of the mean value of the other items on that scale or subscale. Larger amounts of missing data were managed by adopting a pairwise exclusion approach.
Patient actors' Likert scale responses were analysed with content analysis 42 to identify categories in open-ended written responses. These categories were developed inductively from the data (i.e. using emergent rather than predetermined ideas), and a researcher (A.L.H.) not involved in data collection independently second coded these data. Categories identified by the two coders were subsequently compared and ambiguities resolved via discussion.
Intervention content and procedure
The following description of the training intervention is consistent with the 'Template for Intervention Description and Replication (TIDier) guidelines'. 43 The Pso Well â training programme was designed in line with current recommendations for psoriasis management 43, 44 and behaviour change methods. 33, 45 Content was supplemented by additional recommendations from research team members involved in reviewing more up-to-date research evidence on psoriasis. 1, 3, 26, [28] [29] [30] [31] 46, 47 This 1-day intensive training programme aimed to enable the clinicians to adopt a patient-centred consultation approach and applied MI skills. Skills taught to clinicians addressed the core MI processes -engaging, focusing, evoking and planning. The MI literature provides further detail on these principles, 48 and their evidence base.
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The 1-day face-to-face training session was delivered in private university or hospital training rooms and delivered by C.B. and A.C. for consistency; both are psychologists trained in MI and experienced in delivering MI-based workshops to a range of clinicians. During training, research was presented demonstrating the links between psoriasis and modifiable behavioural factors (i.e. smoking, alcohol, obesity, physical activity, low mood and medication adherence). MI skill-building activities were presented using a consistent structure, namely: (i) learning about new skills; (ii) watching skills demonstration; (iii) individual skills practice; and (iv) feedback or coaching on skills use.
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Embedded qualitative study A purposive sample of trainees, with a broad range of characteristics (e.g. profession, sex, training session attended), was invited to complete a semistructured interview to explore their experiences and perceptions of the Pso Well â training. Invitations to interview were made face to face immediately following training, and the researchers (A.C. and C.J.P.) followed up to arrange interviews with those expressing interest. Interview topics focused on clinicians' experiences and views of the training content, delivery and assessment methods. Interviews were digitally audio recorded, transcribed verbatim and analysed using an inductive thematic analysis. 51 Appendix S1 (see Supporting Information) provides further detail on the methodological approach undertaken.
Results
Recruitment
Sixty-one clinicians attended training; it was not possible to identify the exact numbers of clinicians invited to participate in the study due to third parties forwarding on invitations to whole organizations and membership lists. Of the 61 participants, six did not complete the pre-and/or post-training audio-taped consultations. Three clinicians were unwilling to complete patient actor consultations due to low confidence in their anticipated performance, one clinician was absent post-training and two technical faults occurred. This resulted in five audio recordings being omitted from the analysis; these were instead used for training of the BECCI rater team. In total, 110 audio recordings were included in the BECCI analysis. Training courses ran across the U.K. with between five and 15 clinicians; of the 61 attendees, 53 were female (87%). Purposive sampling based on a range of characteristics (Table 1 ) resulted in 18 clinicians completing a posttraining qualitative interview (17 by telephone and one face to face).
Clinicians' motivational interviewing skills
A paired-samples t-test was conducted on the BECCI data to evaluate the impact of the Pso Well â training on clinicians'
(n = 55) MI skills. There was a statistically significant increase in BECCI scores from before training (mean AE SD, 0Á50 AE 0Á47) to after training: mean AE SD, 1Á26 AE 0Á71, t(54) = 8Á37, P < 0Á001 (two tailed). The mean increase in BECCI scores was 0Á76 (95% CI 0Á57-0Á94). The g 2 statistic Figure 1 illustrates the mean BECCI scores before and after training. Figure 2 shows the BECCI scores broken down by domain pre-and post-training. Percentages are calculated here because the potential maximum total scores on each domain varied between four and 20 points. Table 2 displays descriptive data illustrating pre-and post-training BECCI scores organized by clinician group. Figure 3 illustrates the mean clinician 'talk time' estimated by raters before and after attending the training. A paired-samples t-test was used to compare the proportion of the consultation time in which the clinicians spoke during patient actor consultations before and after the Pso Well â training (n = 55).
There was a statistically significant decrease in talk time from pretraining (mean AE SD, 58Á4 AE 15Á9%) to post-training: mean AE SD, 47Á2 AE 11Á5, t(54) = 6Á22, P < 0Á001. The mean decrease in clinician talk time was 11Á2% (95% CI 7Á6-14Á8). The g 2 statistic (0Á42) indicated a large effect size. 52 Scores from the scale completed by patient actors indicated greater improvement in clinicians' consultation approaches post-training (Fig. 4) . The content analysis of the actors' open-text responses identified differences in the consultation approach before and after training. These differences are outlined in Table 3 .
Clinicians' knowledge of psoriasis-related comorbidities and risk factors
A paired-samples t-test was conducted on the survey data to assess the change in levels of clinicians' knowledge following the Pso Well â training. Statistically significant increases were found for participants' knowledge of risk factor prevalence [t(60) = 4Á30, P < 0Á001; pretraining mean AE SD, 5Á82 AE 1Á21, post-training mean AE SD, 6Á47 AE 0Á93] and the mechanisms linking psoriasis and risk factors [t (60) = 7Á12, P < 0Á001; pretraining mean AE SD, 11Á52 AE 3Á70, post-training mean AE SD, 14Á21 AE 3Á66], but not regarding knowledge of psoriasis-related comorbidities (P = 0Á096) (Fig. 5) . Table 4 displays descriptive data illustrating pre-and posttraining knowledge scores categorized by clinician group (primary-care clinician, dermatologist, specialist nurse). Figures 6 and 7 show the number and type of change topics discussed during audio-taped consultations, before and after training. A Wilcoxon signed-rank test showed no significant difference (z = 1Á32, P = 0Á19) in the extent to which clinicians linked psoriasis and these change topics during consultations, pre-and post-training. This was measured using a single-item, 'Did the clinician make links between psoriasis and behaviour change topics?' attend' and 'trade-offs when undergoing assessment'. Overall, the clinicians reported that the training enabled acquisition of novel consultation skills that were relevant and useful in the management of psoriasis. They highlighted the contrast between standard care and the more patientcentred/holistic approach used within the training. Clinicians also noted that for this approach to be fully embedded within their practice, they would require further coaching/feedback on their use of MI skills in practice. The full thematic structure, alongside anonymized illustrative quotes from clinicians, is illustrated in Table S1 (see Supporting Information).
Thematic analysis of qualitative interviews
Discussion
As understanding increases about how behavioural and psychological factors relate to psoriasis, so do calls for effective interventions targeting these factors. 53 The current findings
show that the 1-day Pso Well â training programme enhanced clinicians' ability to use MI skills to address behaviour change in the context of managing psoriasis. The degree of change in MI skills found in this study is equivalent to that demonstrated by other MI training. 54, 55 Our previous work has shown that clinicians' understanding about the relationships between psoriasis and related behavioural and psychological factors is limited, and even when clinicians recognize psoriasis as a complex condition, this understanding may not translate into clinical management approaches. 26 The Pso Well â training therefore aimed to integrate clinicians' understanding and clinical management approaches by providing them with evidence-based behaviour change strategies to use during standard psoriasis consultations. As well as demonstrating increased understanding of the links between psoriasis and lifestyle and mood factors, the findings also showed that following training, clinicians discussed a broader range of these topics within consultations and focused conversations less on medication management alone. Patient actor feedback also illustrates (from a 'proxy' patient perspective) high levels of overall satisfaction with the consultation style used by clinicians following training, which is consistent with core components of MI 48 : partnership (e.g. collaborative care), compassion (e.g. empathy, acknowledgement of people's thoughts/feelings) and evocation (e.g. eliciting patient-led solutions and management plans). Dermatologist (consultant/registrar) (n = 22) 0Á37 AE 0Á20 1Á35 AE 0Á76 0Á98 Primary-care clinician (general practitioner, healthcare assistant, primary-care nurse) (n = 6)
Nurse specialist (secondary care) (n = 27) 0Á60 AE 0Á61 1Á16 AE 0Á69 0Á56 It was notable that following training, clinicians' knowledge of psoriasis-related comorbidities did not increase, nor were they more likely to explain to patients how psoriasis and behavioural factors are associated. This may have been because the training focused less on the relationships between psoriasis-associated conditions and behaviours per se, and more on how to address behaviour change with patients. Addressing behavioural factors as part of psoriasis management is important because modification of lifestyle factors, medication adherence and low mood can improve psoriasis outcomes and reduce the likelihood of developing or exacerbating psoriasisrelated comorbidities. 56 Given that clinicians often do not opportunistically or systematically discuss these issues with patients, 26, 28, 30, 31 training such as Pso Well â is needed to support clinicians with this task. Despite not indicating an increase in clinicians' knowledge about psoriasis comorbidities, the Pso Well â training can change clinicians' approaches to psoriasis management discussions in line with current recommendations. 44 Moreover, this shift in approach can be carried out within the context of a 10-min consultation about psoriasis. Measuring the effects of this training intervention on patient outcomes within a controlled trial is now warranted. Consistently with the Medical Research Council guidance for complex intervention design, 32 this study also allowed us to explore the extent to which clinicians endorsed the training as relevant, useful and usable within clinical practice. The qualitative findings indicate both that the Pso Well â training is feasible to conduct and evaluate within existing healthcare settings, and that clinicians are satisfied with the training content, delivery and assessment methods chosen. Although the clinicians within this study were self-selected and thus potentially more skilled or predisposed to this approach, 57 the baseline scores indicated little or no experience of using MI skills. This suggests that even those who were enthusiastic about or familiar with MI techniques benefited from training. As the sample included mostly secondarycare clinicians, the results cannot be generalized to the management of psoriasis by primary-care professionals. Further work is necessary to explore the impact of this training on clinical management approaches to psoriasis conducted within general-practice settings. Finally, recruitment to the training highlighted that secondary-care clinicians are more likely to attend than general practitioners (with or without a special interest in dermatology). Barriers to engaging with or attending this training should therefore be explored with this professional group. This study shows that the Pso Well â training programme can enhance standard clinical management of psoriasis to include an MI-consistent approach to addressing a range of psoriasis-related behavioural risk factors. Furthermore, it is likely that clinicians will engage with this training and find it useful for practice. The findings warrant further investigation of how this holistic approach to care could affect psoriasis outcomes within current clinical settings. Type of topics discussed during clinician-patient actor consultations before and after attending training (n = 55).
